Idiopathic Pulmonary Fibrosis - Asia Pacific – Clinical Trial Landscape

The global burden of IPF is expected to rise, due to the rapidly aging population of Asia Pacific region, with South Korea, in particular, having the highest incidence and prevalence rates of IPF.